Microbot Medical Inc reports results for the quarter ended June 30 - Earnings Summary

Microbot Medical

11/08/2026 15:14

Microbot Medical Inc MBOT.OQ reported a quarterly adjusted loss of 8 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -10 cents.  The mean expectation of three analysts for the quarter was for a loss of 8 cents per share. Wall Street expected results to range from -9 cents to -6 cents per share.
Revenue was $241.00 thousand​; analysts expected $340.00 thousand. 
Microbot Medical Inc's reported EPS for the quarter was a loss of 8 cents​.
The company reported a quarterly loss of $5.63 million.
Microbot Medical Inc shares had fallen by 0.8% this quarter and lost 3.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 9.8% in the last three months.​ 
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Microbot Medical Inc is $5.00, about 61.3% above its last closing price of $1.94
This summary was machine generated from LSEG data August 11 at 02:14 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.08
-0.08
Met
Mar. 31 2026 
-0.08
-0.05
Beat
Dec. 31 2025 
-0.06
-0.04
Beat
Sep. 30 2025 
-0.06
-0.07
Missed